Alx Oncology Holdings (ALXO) Payables (2019 - 2026)

Alx Oncology Holdings has reported Payables for 8 years, with the latest figure at $3.9 million in Q1 2026.

• Quarterly Payables fell 2.11% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 2.11% YoY) and the FY2025 annual result came in at $4.9 million, up 9.27% from the prior year.
• Payables eased to $3.9 million in Q1 2026 per ALXO's latest filing, from $4.9 million in the prior quarter.
• Over five years, Payables peaked at $13.0 million in Q3 2023 and troughed at $3.9 million in Q1 2026.
• A 5-year average of $6.7 million and a median of $6.2 million in 2024 frame the typical range for Payables.
• The widest YoY moves for Payables: up 121.11% in 2023, down 52.59% in 2023.
• Over 5 years, Payables stood at $8.1 million in 2022, then advanced by 6.42% to $8.6 million in 2023, then plunged by 47.65% to $4.5 million in 2024, then increased by 9.27% to $4.9 million in 2025, then slipped by 21.57% to $3.9 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $3.9 million, $4.9 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.